PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2129065
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2129065
Organic Capsules Market size was valued at US$ 660.2 Million in 2025, expanding at a CAGR of 7.7% from 2026 to 2033.
Organic capsules are plant-derived capsule dosage forms used for the delivery of nutritional, pharmaceutical, cosmetic, and other active formulations. The market is increasingly defined not just by replacing gelatin, but by combining organic certification, plant-based composition, formulation protection, and capsule-processing performance. In 2025, Lonza Capsugel introduced Organicaps(TM), marketed as the first USDA organic-certified, plant-based immediate-release pullulan capsule made in North America. The shell also provides high oxygen-barrier properties and is non-GMO Project verified. Lonza's 2025 capsule portfolio also featured hard empty capsules, dosage-form solutions, and health ingredients, signaling suppliers are moving toward integrated formulation and delivery capabilities. Therefore, competitive differentiation is shifting to certified materials, ingredient protection, and clean label functionality, instead of just the capsule composition.
Organic Capsules Market- Market Dynamics
Organic Certification Is Becoming a Formulation-Level Differentiator
The organic positioning of the finished supplement is playing an increasingly influential role in capsule selection as manufacturers have to match the dosage form with the product's broader clean-label proposition. In 2025, Lonza reported that 73% of consumers are influenced by the presence of organic ingredients, while 54% are willing to pay more for organic ingredients. The launch of Organicaps was specifically to meet the needs of organic supplement formulations. At the regulatory level, the European Commission requires organic products marketed under the EU framework to comply with defined production, processing, traceability, and certification conditions. Its 2025 trade controls also included additional checks for certain imported organic products. These developments make certification integrity and material traceability increasingly important criteria for choice by capsule suppliers.
The Global Organic Capsules Market is segmented on the basis of Product Type, Application, Material, and Region.
By product type, the product-type-based structure is driven more by the trade-off between flexibility in formulation, processing performance, and the degree of plant-based or organic positioning required by the finished product. Soft capsules retain relevance for liquid/oil-based or semi-solid formulations that need encapsulation across nutrition and beauty-related products. In contrast, hard capsules allow for a more diverse platform for powders, granules, pellets, as well as selected liquid fills, and have emerged as an important carrier for HPMC and pullulan alternatives. Capsugel's HPMC portfolio targets moisture-sensitive contents and high-speed filling, while its Organicaps solution leverages pullulan to combine organic certification with oxygen protection. Thus, the differentiation between soft and hard capsules tends to be more driven by formulation compatibility and certification requirements rather than shell geometry.
By application, the application-based segmentation leads to a more differentiated outlook as the capsule requirements are varied according to the formulation purpose. Health & Nutrition appear to benefit more directly from an investment in organic capsule technology as plant-based materials, clean label positioning, and compatibility with sensitive nutritional ingredients can enrich the product proposition. Pharmaceuticals demand a significantly different priority: dissolution consistency, stability, regulatory compliance, and protection of moisture-sensitive APIs are more critical than organic positioning, and both Qualicaps and Capsugel target HPMC capsules around the technical characteristics. Cosmetics and other product categories broaden significance toward ingestible beauty, specialty wellness, and functional formulations, but remain largely formulation-specific. As such, the application competition increasingly pertains to the ability of capsule manufacturers to offer differentiated shell materials and delivery characteristics for differing formulation environments.
Organic Capsules Market- Geographical Insights
North America has become a significant base for innovation and commercialization of organic capsule solutions. The region is projected to witness an upsurge in organic capsule technology developments, which is evident from the events occurring in 2025. For instance, Lonza Capsugel introduced Organicaps(TM) as a plant-based organic and natural immediate-release pullulan capsule produced in North America and available for sale in the region in October 2025. The company specified the product's oxygen barrier, inert nature of the shell, polymer integrity, and fill performance characteristics, emphasizing organic certification and formulation protection. In October 2025, ACG announced the opening of dedicated U.S. hard-shell capsule manufacturing for gelatin and HPMC products. Therefore, North America is an essential region for organic capsule manufacturing due to product design and local production capabilities.
Asia-Pacific region is critical to the organic capsule market due to the presence of end-use industries that rely on local manufacturing and capsule production networks in India, China, and Japan. For instance, Lonza's APAC Leadership reported in January 2025 that their production facilities in China, Japan, and India were supplying pharmaceutical and nutraceutical capsule solutions. At the same time, the organic capsule market in the APAC region is linked to HPMC technology, formulation design capabilities, and localized production of dosage forms. In 2025, ACG's portfolio comprised cellulose-based HPMC capsules that could address the needs of moisture-sensitive and hygroscopic formulations. The company's extensive manufacturing network supports its ability to offer organic capsule technologies in the Asia-Pacific region.
Competition is focused on alternative suppliers that can offer a combination of capsule material expertise, large-scale production, formulation support, customization, and regulatory know-how. Lonza Capsugel's main strength is the variety of its plant-based solutions (HPMC and pullulan) combined with its capsule development and dosage form services. The 2025 launch of Organicaps provides the company with an additional competitive advantage by meeting the demand for organic pullulan. ACG's competitive edge is based on providing an integrated ecosystem that includes not only capsule manufacturing but also machines, packaging, inspection, and traceability. Qualicaps is positioned in terms of its technical expertise to supply HPMC capsules for the pharmaceutical market with a specialization in moisture and hygroscopic sensitive materials. As a result, the competitive landscape is shifting towards technical and material capabilities, integrated support, and proximity to the supply chain, and away from commodity capsule production.
In October 2025, Lonza Capsugel presented Organicaps(TM), a plant-based, immediate-release pullulan capsule, at SupplySide Global 2025. The capsule was the first USDA organic-certified capsule produced in North America and featured a high oxygen barrier, non-reactive shell, and non-GMO Project verification.
In October 2025, ACG announced a new U.S. hard-shell capsule manufacturing program, including gelatin and vegetarian HPMC capsules for the first time. The launch began in a newly constructed Atlanta facility, and the program is expected to create over 200 jobs and strengthen localized supply for North American customers.